Inferra AI / Company / HLF
Herbalife Ltd..
HLF · Consumer Staples
Last earnings Aug 5, 2026
Key results
EPSquarter
$192.4 million
Q2 ’24 Credit Agreement EBITDA 1 of $192.4 million Total leverage ratio remained unchanged at 3.0x at June 30 Diluted EPS of $0.48; adjusted diluted EPS 1 $0.59 Net cash provided by operating activities of $96.0 million; capital expenditures of $22.8 million Recent Developments In July, launched MultiBurn™, an all-new, multifunctional weight-loss supplement supporting metabolic health Unveiled beta version of Pro2col™ digital platform and healthy lifespan supplement at North America Extravaganza in July 1 Non-GAAP measure.
SEC original ↗Herbalife Ltd.. — Earnings release (8-K exhibit)EX-99Aug 6, 2025
Adjusted EPSquarter
$0.59
Q2 ’24 Credit Agreement EBITDA 1 of $192.4 million Total leverage ratio remained unchanged at 3.0x at June 30 Diluted EPS of $0.48; adjusted diluted EPS 1 $0.59 Net cash provided by operating activities of $96.0 million; capital expenditures of $22.8 million Recent Developments In July, launched MultiBurn™, an all-new, multifunctional weight-loss supplement supporting metabolic health Unveiled beta version of Pro2col™ digital platform and healthy lifespan supplement at North America Extravaganza in July 1 Non-GAAP measure.
SEC original ↗Herbalife Ltd.. — Earnings release (8-K exhibit)EX-99Aug 6, 2025
Capexquarter
$22.8 million
Q2 ’24 Credit Agreement EBITDA 1 of $192.4 million Total leverage ratio remained unchanged at 3.0x at June 30 Diluted EPS of $0.48; adjusted diluted EPS 1 $0.59 Net cash provided by operating activities of $96.0 million; capital expenditures of $22.8 million Recent Developments In July, launched MultiBurn™, an all-new, multifunctional weight-loss supplement supporting metabolic health Unveiled beta version of Pro2col™ digital platform and healthy lifespan supplement at North America Extravaganza in July 1 Non-GAAP measure.
SEC original ↗Herbalife Ltd.. — Earnings release (8-K exhibit)EX-99Aug 6, 2025
Net incomequarter
$49.3 million
For the quarter, net income attributable to Herbalife was $49.3 million, with net income margin of 3.9% and adjusted net income 1 of $60.5 million.
SEC original ↗Herbalife Ltd.. — Earnings release (8-K exhibit)EX-99Aug 6, 2025
Adjusted net incomequarter
$60.5 million
For the quarter, net income attributable to Herbalife was $49.3 million, with net income margin of 3.9% and adjusted net income 1 of $60.5 million.
SEC original ↗Herbalife Ltd.. — Earnings release (8-K exhibit)EX-99Aug 6, 2025
Diluted EPS was $0.48, with adjusted diluted EPS 1 of $0.59, which includes a $0.11 year-over-year foreign currency headwind.
SEC original ↗Herbalife Ltd.. — Earnings release (8-K exhibit)EX-99Aug 6, 2025
AI analysis
Q2 2025 · reported Aug 6, 2025
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
Headline figures
| Metric | Q2 2025 | Prior qtr | Year ago |
|---|---|---|---|
| EPS | $192.4 million | — | — |
| Adjusted EPS | $0.59 | — | — |
| Capex | $22.8 million | — | — |
| Net income | $49.3 million | — | — |
| Adjusted net income | $60.5 million | — | — |
Guidance · company-stated
Direction: Raised
“Outlook Third quarter 2025 guidance provided Full-year 2025 guidance revised: raised net sales and adjusted EBITDA 1 , capital expenditures reduced Management Commentary Herbalife reported second quarter 2025 net sales of $1.3 billion, down 1.7% year-over-year, including 170 basis points of foreign currency headwinds.”
Classified from the release's primary full-year outlook statement.
Cash flow & capex
Capital allocation
Q2 ’24 Credit Agreement EBITDA 1 of $192.4 million Total leverage ratio remained unchanged at 3.0x at June 30 Diluted EPS of $0.48; adjusted diluted EPS 1 $0.59 Net cash provided by operating activities of $96.0 million; capital expenditures of $22.8 million Recent Developments In July, launched MultiBurn™, an all-new, multifunctional weight-loss supplement supporting metabolic health Unveiled beta version of Pro2col™ digital platform and healthy lifespan supplement at North America Extravaganza in July 1 Non-GAAP measure.
Event summary
ISSUED BY HERBALIFE LTD
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
Guidance & outlook
Direction: Raised
Revenue: “Outlook Third quarter 2025 guidance provided Full-year 2025 guidance revised: raised net sales and adjusted EBITDA 1 , capital expenditures reduced Management Commentary Herbalife reported second quarter 2025 net sales of $1.3 billion, down 1.7% year-over-year, including 170 basis points of foreign currency headwinds.”
Revenue — Raised (“Raises”)
“ON AUGUST 6, 2025, REGARDING EARNINGS RELEASE Exhibit 99.1 Herbalife Reports Q2 Net Sales Near Guidance Midpoint; Q2 Adjusted EBITDA 1 Exceeds Guidance; Raises Net Sales and Adjusted EBITDA 1 Full-Year Guidance Highlights MultiBurn™ Launch and Unveiling of Beta Version of Pro2col App and Healthy Lifespan Supplement LOS ANGELES , August 6, 2025 – Herbalife Ltd.”
Revenue — Raised (“raised”)
“Outlook Third quarter 2025 guidance provided Full-year 2025 guidance revised: raised net sales and adjusted EBITDA 1 , capital expenditures reduced Management Commentary Herbalife reported second quarter 2025 net sales of $1.3 billion, down 1.7% year-over-year, including 170 basis points of foreign currency headwinds.”
Revenue — Raised (“raised”)
““We delivered solid second-quarter results and raised our full-year net sales and adjusted EBITDA 1 guidance,” said Stephan Gratziani.”
Classified from the release's primary full-year outlook statement.
Capital allocation
Q2 ’24 Credit Agreement EBITDA 1 of $192.4 million Total leverage ratio remained unchanged at 3.0x at June 30 Diluted EPS of $0.48; adjusted diluted EPS 1 $0.59 Net cash provided by operating activities of $96.0 million; capital expenditures of $22.8 million Recent Developments In July, launched MultiBurn™, an all-new, multifunctional weight-loss supplement supporting metabolic health Unveiled beta version of Pro2col™ digital platform and healthy lifespan supplement at North America Extravaganza in July 1 Non-GAAP measure.
SEC original ↗Herbalife Ltd.. — Earnings release (8-K exhibit)EX-99Aug 6, 2025
Outlook Third quarter 2025 guidance provided Full-year 2025 guidance revised: raised net sales and adjusted EBITDA 1 , capital expenditures reduced Management Commentary Herbalife reported second quarter 2025 net sales of $1.3 billion, down 1.7% year-over-year, including 170 basis points of foreign currency headwinds.
SEC original ↗Herbalife Ltd.. — Earnings release (8-K exhibit)EX-99Aug 6, 2025
Capital expenditures were $22.8 million and $41.1 million for the three and six months ended June 30, 2025, respectively, and capitalized SaaS implementation costs were approximately $4 million and $9 million, respectively.
SEC original ↗Herbalife Ltd.. — Earnings release (8-K exhibit)EX-99Aug 6, 2025
The Company expects to incur total capitalized SaaS implementation costs of approximately $25 million to $30 million for the full year of 2025, which are not included in capital expenditures.
SEC original ↗Herbalife Ltd.. — Earnings release (8-K exhibit)EX-99Aug 6, 2025
As previously disclosed, in June 2025 the Company redeemed $50.0 million aggregate principal amount of the 7.875% Senior Notes due 2025 (“2025 Notes”) for an aggregate purchase price of $51.3 million, which included $1.3 million of accrued and unpaid interest.
SEC original ↗Herbalife Ltd.. — Earnings release (8-K exhibit)EX-99Aug 6, 2025
In addition, the Company’s revolving credit facility was undrawn as of June 30.
SEC original ↗Herbalife Ltd.. — Earnings release (8-K exhibit)EX-99Aug 6, 2025
Strategy & priorities
” The Company’s distributor growth initiatives drove continued engagement in the second quarter, supported by the global launch of the all-new Herbalife Flex45 Challenge — a distributor engagement program centered on health, product use, personal development and business fundamentals — and sustained momentum from the Herbalife Premier League training and recognition program, initially launched at the end of the first quarter of 2024.
SEC original ↗Herbalife Ltd.. — Earnings release (8-K exhibit)EX-99Aug 6, 2025
All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management, including for future operations, capital expenditures, or share repurchases; any statements concerning proposed new products, services, or developments; any statements regarding future economic conditions or performance; any statements of belief or expectation; and any statements of assumptions underlying any of the foregoing or other future events.
SEC original ↗Herbalife Ltd.. — Earnings release (8-K exhibit)EX-99Aug 6, 2025
” Adjusted net income, adjusted diluted EPS, adjusted EBITDA and credit agreement EBITDA are calculated as net income attributable to Herbalife excluding the impact of certain unusual or non-recurring items such as expenses related to restructuring initiatives, expenses related to the digital technology program, gains or losses from sale of property, gains or losses from extinguishment of debt and certain tax expenses and benefits, as further detailed in the reconciliations below.
SEC original ↗Herbalife Ltd.. — Earnings release (8-K exhibit)EX-99Aug 6, 2025
2023-06, Disclosure Improvements: Codification Amendments in Response to the SEC s Disclosure Update and Simplification Initiative , which amends the disclosure or presentation requirements of a variety of topics in the accounting standards codification (the ASC ) in order to conform with certain SEC amendments in Release No.
SEC original ↗Herbalife Ltd.. — 10-Q Quarterly report10-QAug 5, 2026
This ASU clarifies certain aspects of the hedge accounting guidance and addresses additional issues arising from the global reference rate reform initiative.
SEC original ↗Herbalife Ltd.. — 10-Q Quarterly report10-QAug 5, 2026
Risks & headwinds
Q2 ’24 Includes 170 basis points of FX headwinds Flat year-over-year on constant currency basis 2 ; near low end of guidance range Net income attributable to Herbalife of $49.3 million; adjusted net income 1 $60.5 million Adjusted EBITDA 1 of $173.6 million exceeds guidance Adjusted EBITDA 1 at constant currency 2 of $189.6 million exceeds guidance Adjusted EBITDA 1 margin down 30 basis points vs.
SEC original ↗Herbalife Ltd.. — Earnings release (8-K exhibit)EX-99Aug 6, 2025
Outlook Third quarter 2025 guidance provided Full-year 2025 guidance revised: raised net sales and adjusted EBITDA 1 , capital expenditures reduced Management Commentary Herbalife reported second quarter 2025 net sales of $1.3 billion, down 1.7% year-over-year, including 170 basis points of foreign currency headwinds.
SEC original ↗Herbalife Ltd.. — Earnings release (8-K exhibit)EX-99Aug 6, 2025
On a year-over-year basis, gross profit margin primarily benefited from approximately 70 basis points of pricing and approximately 20 basis points from lower inventory write-downs, partially offset by approximately 60 basis points of foreign currency headwinds and 10 basis points of input cost inflation.
SEC original ↗Herbalife Ltd.. — Earnings release (8-K exhibit)EX-99Aug 6, 2025
Adjusted EBITDA 1 of $173.6 million includes approximately $16 million of foreign currency headwinds year-over-year, with adjusted EBITDA 1 margin of 13.8%, down 30 basis points versus the second quarter of 2024.
SEC original ↗Herbalife Ltd.. — Earnings release (8-K exhibit)EX-99Aug 6, 2025
Diluted EPS was $0.48, with adjusted diluted EPS 1 of $0.59, which includes a $0.11 year-over-year foreign currency headwind.
SEC original ↗Herbalife Ltd.. — Earnings release (8-K exhibit)EX-99Aug 6, 2025
” The Company’s distributor growth initiatives drove continued engagement in the second quarter, supported by the global launch of the all-new Herbalife Flex45 Challenge — a distributor engagement program centered on health, product use, personal development and business fundamentals — and sustained momentum from the Herbalife Premier League training and recognition program, initially launched at the end of the first quarter of 2024.
SEC original ↗Herbalife Ltd.. — Earnings release (8-K exhibit)EX-99Aug 6, 2025
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
32 documents- Q2 2026
- 8-KHLF
Aug 31, 2026
- 10-QHLF
Aug 5, 2026
- 8-KHLF
Aug 5, 2026
- Q1 2026
- 10-QHLF
May 6, 2026
- 8-KHLF
May 6, 2026
- 8-KHLF
May 1, 2026
- 8-KHLF
Apr 16, 2026
- 8-KHLF
Apr 14, 2026
- EX-99HLF
Apr 14, 2026
- Q4 2025
- 10-KHLF
Feb 18, 2026
- 8-KHLF
Feb 18, 2026
- Q3 2025
- 10-QHLF
Nov 5, 2025
- 8-KHLF
Nov 5, 2025
- Q2 2025
- 10-QHLF
Aug 6, 2025
- 8-KHLF
Aug 6, 2025
- Q1 2025
- 8-KHLF
Jun 16, 2025
- 10-QHLF
Apr 30, 2025
- 8-KHLF
Apr 30, 2025
- 8-KHLF
Apr 25, 2025
- Q4 2024
- 10-KHLF
Feb 19, 2025
- 8-KHLF
Feb 19, 2025
- EX-99HLF
Feb 19, 2025
- 8-KHLF
Feb 12, 2025
- 8-KHLF
Jan 30, 2025
- Q3 2024
- 10-QHLF
Oct 30, 2024
- 8-K/AHLF
Oct 30, 2024
- 8-KHLF
Oct 30, 2024
- Q2 2024
- 10-QHLF
Jul 31, 2024
- 8-KHLF
Jul 31, 2024
- Q1 2024
- 8-KHLF
Jun 26, 2024
- 10-QHLF
May 1, 2024
- 8-KHLF
May 1, 2024
Earnings releases
13 documentsPresentations
0 documentsNo presentations for Herbalife Ltd.. are held in this edition of the library.
Transcripts
0 documentsNo transcripts for Herbalife Ltd.. are held in this edition of the library.
See also the earnings calendar for every tracked company’s next earnings date.